
The episode discusses various studies related to skin cancer treatment costs and associated risks, along with other dermatological conditions.
This week, the DoD tackle studies that leave plenty of room for debate—from skin cancer treatment costs and melanoma risk to HS, alopecia areata, and the real-world decisions that don't always come with straightforward answers.
Organizations: DoD
Books & works: The Gray Zone Strikes Again
Places: skin cancer, melanoma, HS, alopecia areata
Explore listener stats, chart rankings, contacts and more on the Derms on Drugs podcast page.